Literature DB >> 26152292

The immunomodulatory function of mesenchymal stem cells: mode of action and pathways.

Antonio Uccelli1,2, Nicole Kerlero de Rosbo1.   

Abstract

Mesenchymal stem cells (MSCs) are being increasingly investigated as a therapeutic alternative, not only for their possible regenerative potential but also for their immunomodulatory action, which is being exploited for controlling diseases associated with inflammation. Understanding their direct and indirect target cells, as well as their mode of action and relevant pathways, is a prerequisite for the appropriate and optimal use of MSCs in therapy. Here, we review recent findings on the effects of MSCs on adaptive and innate immune cells. We also consider the impact of the environment on MSC profile, both anti- and proinflammatory, and the mechanisms and molecular pathways through which their effects are mediated, both at the MSC and target cell levels.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  immunity; mediators; mesenchymal stem cells; molecular mechanisms; pathways

Mesh:

Year:  2015        PMID: 26152292     DOI: 10.1111/nyas.12815

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  71 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

Review 2.  Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells.

Authors:  Sabrina Ceccariglia; Anna Cargnoni; Antonietta Rosa Silini; Ornella Parolini
Journal:  Autophagy       Date:  2019-06-18       Impact factor: 16.016

Review 3.  Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.

Authors:  Norberto Perico; Federica Casiraghi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2017-11-30       Impact factor: 10.121

4.  Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.

Authors:  Sofia Avnet; Gemma Di Pompo; Tokuhiro Chano; Costantino Errani; Arig Ibrahim-Hashim; Robert J Gillies; Davide Maria Donati; Nicola Baldini
Journal:  Int J Cancer       Date:  2017-03-15       Impact factor: 7.396

5.  Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways.

Authors:  William H Wheat; Lyndah Chow; Jade N Kurihara; Daniel P Regan; Jonathan W Coy; Tracy L Webb; Steven W Dow
Journal:  Stem Cells Dev       Date:  2016-12-22       Impact factor: 3.272

6.  New ex vivo model of corneal endothelial phacoemulsification injury and rescue therapy with mesenchymal stromal cell secretome.

Authors:  Majid Rouhbakhshzaeri; Behnam Rabiee; Nathalie Azar; Elham Ghahari; Ilham Putra; Medi Eslani; Ali R Djalilian
Journal:  J Cataract Refract Surg       Date:  2018-12-07       Impact factor: 3.351

7.  Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats.

Authors:  María F Zappa Villar; Juliette López Hanotte; Joaquín Pardo; Gustavo R Morel; Guillermo Mazzolini; Mariana G García; Paula C Reggiani
Journal:  Mol Neurobiol       Date:  2019-08-10       Impact factor: 5.590

Review 8.  The progress of early growth response factor 1 and leukemia.

Authors:  Jing Tian; Ziwei Li; Yang Han; Tao Jiang; Xiaoming Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 9.  Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Winston W-Y Kao
Journal:  Ocul Surf       Date:  2016-01-12       Impact factor: 5.033

10.  Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.

Authors:  Jae Hoon Lee; Jeonghyun Park; Jae-Woo Lee
Journal:  Transfusion       Date:  2018-11-01       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.